Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes.

Publication ,  Journal Article
Herndon, LW; Choudhri, SA; Cox, T; Damji, KF; Shields, MB; Allingham, RR
Published in: Arch Ophthalmol
September 1997

OBJECTIVE: To determine the relationship between central corneal thickness (CCT) and applanation intraocular pressure (IOP) in normal, glaucomatous, and ocular hypertensive eyes. METHODS: One hundred nine subjects (184 eyes) were studied. Forty-eight patients (74 eyes) had glaucoma, 28 patients (51 eyes) had ocular hypertension, and 33 patients (59 eyes) were normal. Intraocular pressure as measured by applanation tonometry, refractive status, CCT, and axial length were measured for all subjects. RESULTS: The CCT (mean +/- SD) of eyes with ocular hypertension was significantly greater (0.606 +/- 0.041 mm) than that of glaucomatous eyes (0.554 +/- 0.022 mm) (P < .001) or of normal controls (0.561 +/- 0.026 mm) (P < .001). There was no significant difference in CCT between normal and glaucomatous eyes (P = .40). The axial length (mean +/- SD) of eyes with ocular hypertension (23.54 +/- 1.34 mm) was not different compared with glaucomatous eyes (23.93 +/- 0.96 mm) (P = .13) or normal eyes (23.62 +/- 1.21 mm) (P = .83). There was no significant difference between the axial length for glaucomatous eyes compared with normal eyes (P = .18). Those eyes with glaucoma being treated with topical dorzolamide hydrochloride had a significantly increased CCT (0.560 +/- 0.025 mm) compared with those eyes with glaucoma not being treated with dorzolamide (0.551 +/- 0.20 mm) (P = .02). CONCLUSIONS: The mean CCT is increased in eyes with ocular hypertension when compared with normal or glaucomatous eyes, which confirms the findings of other investigators. Increased CCT may give an artificially high IOP measurement by applanation tonometry. The CCT must be considered when developing a treatment approach for patients with ocular hypertension.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Arch Ophthalmol

DOI

ISSN

0003-9950

Publication Date

September 1997

Volume

115

Issue

9

Start / End Page

1137 / 1141

Location

United States

Related Subject Headings

  • Tonometry, Ocular
  • Thiophenes
  • Sulfonamides
  • Prospective Studies
  • Ophthalmology & Optometry
  • Ocular Hypertension
  • Middle Aged
  • Male
  • Intraocular Pressure
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Herndon, L. W., Choudhri, S. A., Cox, T., Damji, K. F., Shields, M. B., & Allingham, R. R. (1997). Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol, 115(9), 1137–1141. https://doi.org/10.1001/archopht.1997.01100160307007
Herndon, L. W., S. A. Choudhri, T. Cox, K. F. Damji, M. B. Shields, and R. R. Allingham. “Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes.Arch Ophthalmol 115, no. 9 (September 1997): 1137–41. https://doi.org/10.1001/archopht.1997.01100160307007.
Herndon LW, Choudhri SA, Cox T, Damji KF, Shields MB, Allingham RR. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol. 1997 Sep;115(9):1137–41.
Herndon, L. W., et al. “Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes.Arch Ophthalmol, vol. 115, no. 9, Sept. 1997, pp. 1137–41. Pubmed, doi:10.1001/archopht.1997.01100160307007.
Herndon LW, Choudhri SA, Cox T, Damji KF, Shields MB, Allingham RR. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol. 1997 Sep;115(9):1137–1141.

Published In

Arch Ophthalmol

DOI

ISSN

0003-9950

Publication Date

September 1997

Volume

115

Issue

9

Start / End Page

1137 / 1141

Location

United States

Related Subject Headings

  • Tonometry, Ocular
  • Thiophenes
  • Sulfonamides
  • Prospective Studies
  • Ophthalmology & Optometry
  • Ocular Hypertension
  • Middle Aged
  • Male
  • Intraocular Pressure
  • Humans